Directed new share issue in Hofseth BioCare ASA (NO) — NOK 90 million

Carnegie acted as joint lead manager and joint book-runner in the directed new share issue of of 20 million new shares at a subscription price at NOK 4.5 per share. Hofseth BioCare is a Norwegian biomarine company with the key objective to provide high value added biomarine ingredients for human applications.May 2014.